[go: up one dir, main page]

WO1996014314A3 - Thiepane compounds inhibiting and detecting hiv protease - Google Patents

Thiepane compounds inhibiting and detecting hiv protease Download PDF

Info

Publication number
WO1996014314A3
WO1996014314A3 PCT/US1995/014603 US9514603W WO9614314A3 WO 1996014314 A3 WO1996014314 A3 WO 1996014314A3 US 9514603 W US9514603 W US 9514603W WO 9614314 A3 WO9614314 A3 WO 9614314A3
Authority
WO
WIPO (PCT)
Prior art keywords
thiepane
useful
enzymes
hiv protease
compounds inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1995/014603
Other languages
French (fr)
Other versions
WO1996014314A2 (en
Inventor
Norbert W Bischofberger
Choung U Kim
Steven H Krawczyk
Lawrence R Mcgee
Michael J Postich
Wenjin Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/473,876 external-priority patent/US5705524A/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Priority to AU42342/96A priority Critical patent/AU710492B2/en
Priority to NZ297230A priority patent/NZ297230A/en
Priority to JP51552196A priority patent/JP2002515849A/en
Priority to EP95940672A priority patent/EP0789695A2/en
Publication of WO1996014314A2 publication Critical patent/WO1996014314A2/en
Publication of WO1996014314A3 publication Critical patent/WO1996014314A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/04—Seven-membered rings not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Tri- and tetra substituted thiepane compositions having use as immunogens, therapeutics, diagnostics and for other industrial purposes are disclosed. The compositions inhibit proteolytic activity of viral enzymes and are useful for the inhibition of such enzymes as well as in assays for the detection of such enzymes. Embodiments in which antigenic polypeptides are bonded to the compositons are useful in raising antibodies against the thiepane haptens or the polypeptide. Labeled thiepanes of this invention are useful as diagnostic reagents.
PCT/US1995/014603 1994-11-02 1995-11-03 Thiepane compounds inhibiting and detecting hiv protease Ceased WO1996014314A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU42342/96A AU710492B2 (en) 1994-11-04 1995-11-03 Thiepane compounds inhibiting and detecting HIV protease
NZ297230A NZ297230A (en) 1994-11-02 1995-11-03 Thiepane compounds for detecting HIV protease
JP51552196A JP2002515849A (en) 1994-11-04 1995-11-03 Thiepane compounds that inhibit and detect HIV protease
EP95940672A EP0789695A2 (en) 1994-11-04 1995-11-03 Thiepane compounds inhibiting and detecting hiv protease

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US33447194A 1994-11-04 1994-11-04
US08/334,471 1994-11-04
US47086495A 1995-06-06 1995-06-06
US08/470,864 1995-06-06
US08/473,876 1995-06-07
US08/473,876 US5705524A (en) 1994-11-04 1995-06-07 Thiepane compounds
US52204295A 1995-11-02 1995-11-02
US08/522,042 1995-11-02

Publications (2)

Publication Number Publication Date
WO1996014314A2 WO1996014314A2 (en) 1996-05-17
WO1996014314A3 true WO1996014314A3 (en) 1996-06-20

Family

ID=27502493

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/014603 Ceased WO1996014314A2 (en) 1994-11-02 1995-11-03 Thiepane compounds inhibiting and detecting hiv protease

Country Status (5)

Country Link
EP (1) EP0789695A2 (en)
JP (1) JP2002515849A (en)
AU (1) AU710492B2 (en)
CA (1) CA2203570A1 (en)
WO (1) WO1996014314A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9579332B2 (en) 2004-07-27 2017-02-28 Gilead Sciences, Inc. Phosphonate analogs of HIV inhibitor compounds

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
MX9706496A (en) 1995-02-27 1997-11-29 Gilead Sciences Inc Novel selective inhibitors of viral or bacterial neuraminidases.
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5994377A (en) 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
HRP20041113B1 (en) * 2002-04-26 2008-09-30 Gilead Sciences Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
WO2004096287A2 (en) 2003-04-25 2004-11-11 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
EA200501676A1 (en) 2003-04-25 2006-04-28 Джилид Сайэнс, Инк. PHOSPHONATE-CONTAINING KINASE INHIBITORS (OPTIONS), METHOD FOR THEIR RECEIVING, PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL FORM ON THEIR BASIS AND METHOD FOR INHIBING KINASE IN MOLOPYTIC TREATMENT THEM
EA014685B1 (en) 2003-04-25 2010-12-30 Джилид Сайэнс, Инк. Phosphonate-containing antiviral compounds (variants) and pharmaceutical composition based thereon
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US7300924B2 (en) 2003-04-25 2007-11-27 Gilead Sciences, Inc. Anti-infective phosphonate analogs
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
US7427624B2 (en) 2003-10-24 2008-09-23 Gilead Sciences, Inc. Purine nucleoside phosphorylase inhibitory phosphonate compounds
US7432273B2 (en) 2003-10-24 2008-10-07 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
JP2007508844A (en) 2003-10-24 2007-04-12 ギリアード サイエンシーズ， インコーポレイテッド Methods and compositions for the identification of therapeutic compounds
AU2004309418B2 (en) 2003-12-22 2012-01-19 Gilead Sciences, Inc. 4'-substituted carbovir-and abacavir-derivatives as well as related compounds with HIV and HCV antiviral activity
JP5620376B2 (en) 2008-07-08 2014-11-05 ギリアード サイエンシーズ， インコーポレイテッド Salts of HIV inhibitor compounds
ES2892402T3 (en) 2017-08-01 2022-02-04 Gilead Sciences Inc Crystal forms of ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl Ethyl)(phenoxy)phosphoryl)-L-alaninate to treat viral infections

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009297A1 (en) * 1990-11-30 1992-06-11 Smithkline Beecham Corporation Hiv protease inhibitors
WO1993007128A1 (en) * 1991-10-11 1993-04-15 The Du Pont Merck Pharmaceutical Company Cyclic ureas and analogues useful as retroviral protease inhibitiors
WO1994014793A1 (en) * 1992-12-29 1994-07-07 G. D. Searle & Co. Cyclic sulfone containing retroviral protease inhibitors
WO1994019329A1 (en) * 1993-02-26 1994-09-01 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
WO1995002582A1 (en) * 1993-07-14 1995-01-26 Ciba-Geigy Ag Cyclic hydrazine compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009297A1 (en) * 1990-11-30 1992-06-11 Smithkline Beecham Corporation Hiv protease inhibitors
WO1993007128A1 (en) * 1991-10-11 1993-04-15 The Du Pont Merck Pharmaceutical Company Cyclic ureas and analogues useful as retroviral protease inhibitiors
WO1994014793A1 (en) * 1992-12-29 1994-07-07 G. D. Searle & Co. Cyclic sulfone containing retroviral protease inhibitors
WO1994019329A1 (en) * 1993-02-26 1994-09-01 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
WO1995002582A1 (en) * 1993-07-14 1995-01-26 Ciba-Geigy Ag Cyclic hydrazine compounds

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ABBENANTE,G. ET AL.: "Regioselective Structural and Functional Mimicry of Peptides. Design of Hydrolytically-Stable Cyclic Peptidomimetic Inhibitors of HIV-Protease", J.AM.CHEM.SOC., vol. 117, no. 41, 18 October 1995 (1995-10-18), WASHINGTON, pages 10220 - 10226 *
CHENERA,B. ET AL.: "Nonpetitde HIV Protease Inhibitors Designed to Replace a Bound Water", BIOORG.&MED.CHEM.LETT., vol. 3, no. 12, OXFORD, pages 2717 - 2722 *
GHOSH,A.K. ET AL.: "Cyclic Sulfone-3-Carboxamides as Novel P2-Ligands for RO 31-8959 Based HIV-1 Protease Inhibitors", BIOORG.&MED.CHEM.LETT., vol. 5, no. 1, OXFORD, pages 83 - 88 *
JADHAV,P.K. ET AL: "Synthesis of 8-Membered Cyclic Sulfamides : Novel HIV-1 Protease Inhibitors", TETRAHEDRON LETT., vol. 36, no. 36, 4 September 1995 (1995-09-04), OXFORD, pages 6383 - 6386 *
LAM,P.Y.S. ET AL.: "Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors", SCIENCE, vol. 263, 21 January 1994 (1994-01-21), WASHINGTON, pages 380 - 384 *
RANDAD,R. ET AL.: "De Novo Design of Nonpeptidic HIV-1-Protease Inhibitors : Incorporation of Structural Water", BIOORG.&MED.CHEM.LETT., vol. 4, no. 10, OXFORD, pages 1247 - 1252 *
WONG,Y.N. ET AL.: "A Pharmacokinetic Evaluation of HIV Protease Inhibitors, Cyclic Ureas, in Rats and Dogs", BIOPHARM.&DRUG DISPOSITION, vol. 15, pages 535 - 544 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9579332B2 (en) 2004-07-27 2017-02-28 Gilead Sciences, Inc. Phosphonate analogs of HIV inhibitor compounds

Also Published As

Publication number Publication date
AU710492B2 (en) 1999-09-23
AU4234296A (en) 1996-05-31
EP0789695A2 (en) 1997-08-20
CA2203570A1 (en) 1996-05-17
JP2002515849A (en) 2002-05-28
WO1996014314A2 (en) 1996-05-17

Similar Documents

Publication Publication Date Title
WO1996014314A3 (en) Thiepane compounds inhibiting and detecting hiv protease
DE69940429D1 (en) PEPTIDINHIBITORS OF THE NS3 PROTEASE OF HEPATOITIS C VIRUS
EP0891982A3 (en) HIV peptides
HUP9902457A2 (en) Strain selection of pneumococcal surface proteins
NO20020809L (en) Isomeric bonded pyrrolocarbazoles and isoindolines
CA2363947A1 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
ATE71660T1 (en) AUTONOMOUS REPLICATION SEQUENCES FOR YEAST STRAINS OF THE GENUS PICHIA.
EP1308461A3 (en) Antibodies to beta-amyloids or their derivatives and use thereof
WO2002020569A3 (en) Mammalian genes; related reagents and methods
CA2096159A1 (en) Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates
ATE380822T1 (en) FIVE-HELIX PROTEIN
WO2003070187A3 (en) Fusion proteins of mycobacterium tuberculosis
DE59309458D1 (en) Synthetic peptides, antibodies against them and their use
DE69528070D1 (en) NEW LIPOLYTIC ENZYMS
DE69627150D1 (en) METHOD FOR THE PRODUCTION OF ANTIBODIES AGAINST E.COLI BACTERIES OF THE CS4-CFA / 1 FAMILY
WO1999009179A3 (en) Antigen constructs useful in the detection and differentiation of antibodies to hiv
WO2002020555A3 (en) Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components
WO2000035950A3 (en) Reagents and methods useful for detecting diseases of the breast
AU2126400A (en) Detection of small molecules by use of a piezoelectric sensor
EP0725081A4 (en) MONOCLONAL ANTIBODIES AGAINST MxA OF Mx PROTEIN OF MAN
WO1995016040A3 (en) Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
WO1997039029A3 (en) An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
WO1999058638A3 (en) Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections
WO2002102847A1 (en) Novel ligand and dna thereof
WO1999041388A3 (en) Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US US US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US US US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 297230

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2203570

Country of ref document: CA

Ref country code: CA

Ref document number: 2203570

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1995940672

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995940672

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1995940672

Country of ref document: EP